Issue 74, 2015

Lanthanum strontium manganese oxide (LSMO) nanoparticles: a versatile platform for anticancer therapy

Abstract

Lanthanum Strontium Manganese oxide (LSMO) nanoparticles are a new class of magnetic nanoparticles which exhibit favorable magnetic and biological properties. These nanoparticles have opened avenues for multi-modal cancer therapy using hyperthermia, imaging, and diagnosis. Ease of synthesis and facile surface modification makes LSMO nanoparticles promising candidates for application in anti-cancer therapy.

Graphical abstract: Lanthanum strontium manganese oxide (LSMO) nanoparticles: a versatile platform for anticancer therapy

Article information

Article type
Review Article
Submitted
12 Feb 2015
Accepted
24 Jun 2015
First published
24 Jun 2015

RSC Adv., 2015,5, 60254-60263

Author version available

Lanthanum strontium manganese oxide (LSMO) nanoparticles: a versatile platform for anticancer therapy

V. M. Kulkarni, D. Bodas and K. M. Paknikar, RSC Adv., 2015, 5, 60254 DOI: 10.1039/C5RA02731D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements